274 results on '"Byrnes, Catherine A."'
Search Results
2. Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trial
3. Phenotypic Features of Pediatric Bronchiectasis Exacerbations Associated With Symptom Resolution After 14 Days of Oral Antibiotic Treatment
4. Long-term Azithromycin in Children With Bronchiectasis Unrelated to Cystic Fibrosis: Treatment Effects Over Time
5. Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trial
6. Factors in childhood associated with lung function decline to adolescence in cystic fibrosis
7. The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial
8. Social determinants of respiratory health from birth: still of concern in the 21st century?
9. Could automated analysis of chest X-rays detect early bronchiectasis in children?
10. Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices
11. The future of cystic fibrosis care: a global perspective
12. Long Term Outcomes of Randomised Early Exposure to Repeated General Anesthesia in Infants with Cystic Fibrosis
13. RSV severity in New Zealand 2021 and 2022: applying the WHO severity assessment framework
14. Efficacy of oral amoxicillin–clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
15. LONG-TERM HEALTH OUTCOMES OF PAEDIATRIC MULTIFOCAL MUSCULOSKELETAL SEPSIS: A 15-YEAR REVIEW
16. COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020
17. Respiratory Health of Pacific Youth: An Observational Study of Associated Risk and Protective Factors Throughout Childhood
18. Pertussis deaths in New Zealand without community transmission—an infant immunity gap?
19. Sore and tired. A qualitative study exploring the symptom experience of youth with bronchiectasis.
20. Respiratory Health of Pacific Youth: Nutrition Resilience and Risk in Childhood
21. Thoracic Society of Australia and New Zealand ( TSANZ ) position statement on chronic suppurative lung disease and bronchiectasis in children , adolescents and adults in Australia and New Zealand
22. Health-resource use and quality of life in children with bronchiectasis: a multi-center pilot cohort study
23. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years
24. Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand
25. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
26. Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial
27. Disability employment services in Australia: a brief primer
28. Extended Versus Standard Antibiotic Course Duration in Children
29. The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF):a phase 3, randomised, double-blind, placebo-controlled clinical trial
30. Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand.
31. Sore and tired. A qualitative study exploring the symptom experience of youth with bronchiectasis
32. Randomised controlled trial of nebulised gentamicin in children with bronchiectasis
33. Invasive multifocal cryptococcal airway disease in a teenager with hypogammaglobulinaemia
34. Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age
35. On the Control of Certain Deterministic, Infinite-Dimensional by Algebro-Geometric Techniques
36. Surveillance of pediatric parapneumonic effusion/empyema in New Zealand
37. The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma
38. COVID-19 vaccine prioritisation for people with cystic fibrosis
39. Has the time come to end use of the blue inhaler?
40. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
41. Indigenous Children From Three Countries With Non-Cystic Fibrosis Chronic Suppurative Lung Disease/Bronchiectasis
42. A decade on: Follow-up findings of indigenous children with bronchiectasis
43. Early markers of cystic fibrosis structural lung disease: Follow-up of the ACFBAL cohort
44. Factors Associated With Clinical Progression to Severe COVID-19 in People With Cystic Fibrosis: A Global Observational Study
45. A “pretty normal” life: a qualitative study exploring young people’s experience of life with bronchiectasis
46. The Effect of Azithromycin on Structural Lung Disease in Infants with Cystic Fibrosis (COMBAT CF): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Clinical Trial
47. Effect of Bronchoalveolar Lavage–Directed Therapy on Pseudomonas aeruginosa Infection and Structural Lung Injury in Children With Cystic Fibrosis: A Randomized Trial
48. Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?
49. Transitioning from paediatric to adult services with cystic fibrosis or bronchiectasis: What is the impact on engagement and health outcomes?
50. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.